Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07660484

Link Between ASCorbemia Level and Osteoporosis

This monocentric observational study aims to evaluate the association between plasma vitamin C levels (ascorbemia) and the presence of osteoporotic vertebral fractures in patients with osteoporosis. Forty participants will be enrolled at the Rheumatology

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

  • . Patients in group A or B will be seen in consultation or admitted by one of the medical team members among the investigators.
  • . After signing the informed consent and checking the inclusion criteria, the blood sample will be taken by a member of the nursing team of the department.
  • . The collection tube will then be placed in an opaque cooler, refrigerated with ice, and transported to the university hospital's biochemistry lab (routine assay).
  • . Next, the collection of planned clinical and paraclinical data:
  • Diet and risk factors for vitamin C deficiency:
  • Demographic data - osteoporosis risk factors
  • Bone status
  • . Once all the data is collected, we will carry out the statistical analyses, then draft the article, and finally publish it.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men aged 50 yars or older ;
  • Postmenopausal women ;
  • Afilliated with a health insurance and system ;
  • Written informed consent obtained.
  • Group 1 : Clincal osteoporotic vertebral fracture confirmed by imaging within the previous month ; Followed in the Rheumatology department for management of vertebral fracture.
  • Group 2 : Densitometric osteoporosis (T-score ≤ -2.5) ; No history of severe osteoporotic fracture ; No history of clinical or morphometric vertebral fracture.

Exclusion criteria

  • Legal protection measure (guardianship, curatorship);
  • inability to provide informed consent ;
  • refusal to participate ;
  • Vertebral fracture related to tumor,
  • infection, trauma or non osteoporotic causes ;
  • asymptomatic vertebral fracture discovered incidentally ;
  • Severe densitometric osteoporosis for group 2 ;
  • Previous severe osteoporotic fracture for group B.

Treatment and study plan

Plasma vitamin C assessment

Diagnostic Test

Blood sampling for measurement of plasma vitamin C concentration (ascorbemia) in patient of the study

Primary outcomes

  1. Plasma vitamin C concentration

    Time frame: day 1

    Comparison of plasma vitamin C concentration (ascorbemia, µmol/L) between patients with osteoporotic vertebral fractures and patients with osteoporosis without vertebral fracture.

Secondary outcomes

  1. Association between plasma vitamin C level and number of vertebral fractures

    Time frame: day 1

    Assessment of the relationship between plasma vitamin C concentration and the number of osteoporotic vertebral fractures

  2. Association between plasma vitamin C level and lumbar bone mineral density

    Time frame: day 1

    Assessment of the relationship between plasma vitamin C concentration and lumbar spine bone mineral density measured by DXA.

Study contacts

Contact information is provided by the study sponsor or research team.

Marie-charlotte Trojani, Doctor

CONTACT

[email protected]

0492034702

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

ASCO Study: Link Between ASCorbemia Level and Osteoporosis

Acronym: ASCO

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jun 22, 2026
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.